| COVID-19相关生物标志物的临床使用价值研究进展 |
| |
| 引用本文： | 王秋桐,安耀震,刘颖,赵瑞.COVID-19相关生物标志物的临床使用价值研究进展[J].实用心脑肺血管病杂志,2021(4):1-6. |
| |
| 作者姓名： | 王秋桐 安耀震 刘颖 赵瑞 |
| |
| 作者单位： | 沧州医学高等专科学校;河北省沧州市中心医院;首都医科大学附属北京朝阳医院 |
| |
| 摘 要： | COVID-19是一种由新型冠状病毒引起的具有高传染性和死亡率的呼吸系统疾病,病情发展迅速,并伴随致命的并发症,且患者多预后不良。本文归纳总结了C反应蛋白、白介素6、乳酸脱氢酶、中性粒细胞与淋巴细胞比值、淋巴细胞计数、血小板计数、D-二聚体、心肌肌钙蛋白等生物标志物在COVID-19的早期临床辅助诊断、疾病严重程度区分、分级诊疗、病情进展预测和预后改善等方面的积极作用。通过以上分析表明,深入研究生物标志物在COVID-19中的使用价值,能够更好地辅助COVID-19的早期诊断、治疗和预后改善。
|
| 关 键 词： | 新型冠状病毒肺炎 生物学标记物 综述 |
Research Progress of Clinical Application Value of Biomarkers Associated with COVID-19 |
| |
| WANG Qiutong,AN Yaozhen,LIU Ying,ZHAO Rui.Research Progress of Clinical Application Value of Biomarkers Associated with COVID-19[J].Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease,2021(4):1-6. |
| |
| Authors: | WANG Qiutong AN Yaozhen LIU Ying ZHAO Rui |
| |
| Affiliation: | (Cangzhou Medical College,Hebei,China,Cangzhou 061001,China;Cangzhou Central Hospital,Cangzhou 061001,China;Beijing Chao-yang Hospital,Capital Medical University,Beijing 100020,China) |
| |
| Abstract: | COVID-19 is a respiratory disease with high infectivity and mortality caused by novel coronavirus,which develops rapidly,and accompanied by fatal complications and many patients have poor prognosis.This paper summarized the positive role of C-reactive protein,interleukin-6,lactate dehydrogenase,neutrophil to lymphocyte ratio,lymphocyte count,platelet count,D-dimer,cardiac troponin and other biomarkers in early clinical auxiliary diagnosis,disease severity differentiation,hierarchical diagnosis and treatment,disease progression prediction and prognosis improvement of COVID-19.The above analysis shows that in-depth study of the value of biomarkers in the use of COVID-19 can better assist the early diagnosis,treatment and prognosis of COVID-19. |
| |
| Keywords: | COVID-19 Biological markers Review |
| 本文献已被 维普 等数据库收录！ |
|
